Publication | Closed Access

Steady-State Pharmacokinetics of Rivastigmine in Patients with Mild to Moderate Alzheimer’s Disease Not Affected by Co-Administration of Memantine

Alzheimer's DiseasePharmacokinetic ModelingMedicineNeuropharmacologyClinical PharmacologyExperimental PharmacologyPharmacotherapyNeurologyNeurosciencePharmacologyPharmacokineticsPharmacodynamic ModelingSteady-state PharmacokineticsModerate Alzheimer ’